Diffusion Pharmaceuticals Stock Forecast - Naive Prediction
DFFNDelisted Stock | USD 3.27 0.17 5.48% |
The Naive Prediction forecasted value of Diffusion Pharmaceuticals on the next trading day is expected to be 3.42 with a mean absolute deviation of 0.10 and the sum of the absolute errors of 6.26. Diffusion Stock Forecast is based on your current time horizon.
Diffusion |
Diffusion Pharmaceuticals Naive Prediction Price Forecast For the 25th of November
Given 90 days horizon, the Naive Prediction forecasted value of Diffusion Pharmaceuticals on the next trading day is expected to be 3.42 with a mean absolute deviation of 0.10, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.26.Please note that although there have been many attempts to predict Diffusion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Diffusion Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Diffusion Pharmaceuticals Stock Forecast Pattern
Backtest Diffusion Pharmaceuticals | Diffusion Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Diffusion Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Diffusion Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | 113.9683 |
Bias | Arithmetic mean of the errors | None |
MAD | Mean absolute deviation | 0.1027 |
MAPE | Mean absolute percentage error | 0.0287 |
SAE | Sum of the absolute errors | 6.2631 |
Predictive Modules for Diffusion Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diffusion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Diffusion Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Diffusion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Diffusion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Diffusion Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Diffusion Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Diffusion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Diffusion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Diffusion Pharmaceuticals stock market strength indicators, traders can identify Diffusion Pharmaceuticals entry and exit signals to maximize returns.
Diffusion Pharmaceuticals Risk Indicators
The analysis of Diffusion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Diffusion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting diffusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 2.4 | |||
Standard Deviation | 3.0 | |||
Variance | 8.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Diffusion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diffusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Diffusion Stock
Moving against Diffusion Stock
0.87 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.81 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.81 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.79 | WMT | Walmart Aggressive Push | PairCorr |
0.79 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
The ability to find closely correlated positions to Diffusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diffusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diffusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diffusion Pharmaceuticals to buy it.
The correlation of Diffusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diffusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diffusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diffusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Diffusion Stock
If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |